vfa Forecasts German Pharma Output to Fall 2.2% in 2026

• German pharmaceutical production is forecast to fall 2.2% in 2026, before rebounding 4.3% in 2027, largely on catch-up effects.
• Pharmaceutical investment spending is projected to decline 1.8% in nominal terms in 2027 as statutory cost-cutting measures squeeze profitability.
• Cumulative capital investment and research spending could be more than €4 billion below levels without the additional burdens by 2030.
• The mandatory manufacturer rebate on patent-protected medicines rises from 7% to 15.5% at the start of 2027, reducing investment returns.
• Germany’s economy is forecast to grow 1.3% in 2026, slowing to 1.1% in 2027, with private investment remaining weak.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioM Biotech Cluster Development GmbH published the original content used to generate this news brief on October 23, 2026, and is solely responsible for the information contained therein.